BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 8709209)

  • 41. A role for Sp and helix-loop-helix transcription factors in the regulation of the human Id4 gene promoter activity.
    Pagliuca A; Cannada-Bartoli P; Lania L
    J Biol Chem; 1998 Mar; 273(13):7668-74. PubMed ID: 9516472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element.
    Hua X; Yokoyama C; Wu J; Briggs MR; Brown MS; Goldstein JL; Wang X
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11603-7. PubMed ID: 7903453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erythroid-specific inhibition of the tal-1 intragenic promoter is due to binding of a repressor to a novel silencer.
    Courtes C; Lecointe N; Le Cam L; Baudoin F; Sardet C; Mathieu-Mahul D
    J Biol Chem; 2000 Jan; 275(2):949-58. PubMed ID: 10625632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A splice variant of the ITF-2 transcript encodes a transcription factor that inhibits MyoD activity.
    Skerjanc IS; Truong J; Filion P; McBurney MW
    J Biol Chem; 1996 Feb; 271(7):3555-61. PubMed ID: 8631961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of different basic helix-loop-helix leucine zipper factors on the glucose response unit of the L-type pyruvate kinase gene.
    Moriizumi S; Gourdon L; Lefrançois-Martinez AM; Kahn A; Raymondjean M
    Gene Expr; 1998; 7(2):103-13. PubMed ID: 9699482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes.
    Massari ME; Rivera RR; Voland JR; Quong MW; Breit TM; van Dongen JJ; de Smit O; Murre C
    Mol Cell Biol; 1998 Jun; 18(6):3130-9. PubMed ID: 9584154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines.
    Sawada S; Littman DR
    Mol Cell Biol; 1993 Sep; 13(9):5620-8. PubMed ID: 8355705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An IgH enhancer that drives transcription through basic helix-loop-helix and Oct transcription factor binding motifs. Functional analysis of the E(mu)3' enhancer of the catfish.
    Cioffi CC; Middleton DL; Wilson MR; Miller NW; Clem LW; Warr GW
    J Biol Chem; 2001 Jul; 276(30):27825-30. PubMed ID: 11375977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Negative regulatory element associated with potentially functional promoter and enhancer elements in the long terminal repeats of endogenous murine leukemia virus-related proviral sequences.
    Ch'ang LY; Yang WK; Myer FE; Yang DM
    J Virol; 1989 Jun; 63(6):2746-57. PubMed ID: 2542587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic organization and characterization of the promoter for the E2A gene.
    Hata K; Mizuguchi J
    Gene; 2004 Jan; 325():53-61. PubMed ID: 14697510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolution of transcriptional control of the IgH locus: characterization, expression, and function of TF12/HEB homologs of the catfish.
    Hikima J; Cioffi CC; Middleton DL; Wilson MR; Miller NW; Clem LW; Warr GW
    J Immunol; 2004 Nov; 173(9):5476-84. PubMed ID: 15494495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of pathogenicity and disease specificity of a T-lymphomagenic gammaretrovirus by E-box motifs but not by an overlapping glucocorticoid response element.
    Ejegod D; Sørensen KD; Mossbrugger I; Quintanilla-Martinez L; Schmidt J; Pedersen FS
    J Virol; 2009 Jan; 83(1):336-46. PubMed ID: 18945767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
    Ethelberg S; Lovmand J; Schmidt J; Luz A; Pedersen FS
    J Virol; 1997 Oct; 71(10):7273-80. PubMed ID: 9311802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequence determinants of DNA binding by the hematopoietic helix-loop-helix transcription factor TAL1: importance of sequences flanking the E-box core.
    Gould KA; Bresnick EH
    Gene Expr; 1998; 7(2):87-101. PubMed ID: 9699481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities.
    Sánchez-García I; Rabbitts TH
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7869-73. PubMed ID: 8058726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel enhancer, the pro-B enhancer, regulates Id1 gene expression in progenitor B cells.
    Saisanit S; Sun XH
    Mol Cell Biol; 1995 Mar; 15(3):1513-21. PubMed ID: 7862144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
    Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
    J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A 346-base pair region of the mouse gamma-glutamyl transpeptidase type II promoter contains sufficient cis-acting elements for kidney-restricted expression in transgenic mice.
    Sepulveda AR; Huang SL; Lebovitz RM; Lieberman MW
    J Biol Chem; 1997 May; 272(18):11959-67. PubMed ID: 9115259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. E2A and HEB activate the pre-TCR alpha promoter during immature T cell development.
    Takeuchi A; Yamasaki S; Takase K; Nakatsu F; Arase H; Onodera M; Saito T
    J Immunol; 2001 Aug; 167(4):2157-63. PubMed ID: 11490000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The E47 transcription factor binds to the enhancer sequences of recombinant murine leukemia viruses and influences enhancer function.
    Lawrenz-Smith SC; Thomas CY
    J Virol; 1995 Jul; 69(7):4142-8. PubMed ID: 7769673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.